Previous study indicated that PPARγ activation attenuates lipopolysaccharide-induced inflammation in mouse models, suggesting potential benefits in inflammatory diseases such as chronic obstructive pulmonary disease (COPD) [39]. This evidence concerns the gene PPARG and chronic obstructive pulmonary disease.